Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Chao Center for Industrial Pharmacy and Contract Manufacturing will shut down in the months to come, according to officials of Purdue Research Park. A new manufacturer of small-volume drug batches will be sought to move into the facility.
Subscribe to our email newsletter
The rationale behind the closure is that the Chao Center has not been able to become self-sustaining during its five-year operation.
According to Joseph Hornett, senior vice president, treasurer and COO of the Purdue Research Foundation, contributing factors include the economic downturn and the challenges with producing small-volume drugs.
The Chao Center, on humanitarian grounds, will continue to manufacture and distribute the multidrug-resistant tuberculosis drug Seromycin and other life-saving legacy drugs until new manufacturers are found. As a result of an agreement with Eli Lilly and Co, the Chao Center became the sole producer of Seromycin for patients in North America, in 2007.
Allen and Lee-Hwa Chao, alumni of Purdue University, have gifted $5m through which the center was opened in 2005. The Chao Center is a pharmaceutical manufacturing facility that produces and distributes legacy and small-volume drugs.
The 12 center employees will be provided outplacement services. Transfers for employment opportunities at the Purdue Research Foundation also will be offered if comparable positions are available.